Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Tr...

FDA Drug Recall #D-0581-2018 — Class III — February 28, 2018

Recall Summary

Recall Number D-0581-2018
Classification Class III — Low risk
Date Initiated February 28, 2018
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Osmotica Pharmaceutical Corp
Location Marietta, GA
Product Type Drugs
Quantity 19,664 100-bottles

Product Description

Methylphenidate Hydrochloride Extended-release Tablets, USP, 36 mg, 100-count bottle, Rx only, Trigen Laboratories, LLC Bridgewater, NJ 08807. NDC 13811-708-10

Reason for Recall

Subpotent Drug:100-count product bottle labeled as Methylphenidate HCL ER Tablets 36 mg found to contain 1 27 mg Methylphenidate HCL ER Tablet.

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Lots: 170231B, 170232A, 170233A, 170234A

Other Recalls from Osmotica Pharmaceutical Corp

Recall # Classification Product Date
D-0110-2018 Class III Methylphenidate Hydrochloride Extended-release ... Dec 18, 2017
D-0111-2018 Class III Methylphenidate Hydrochloride Extended-release ... Dec 18, 2017
D-1067-2013 Class III Venlafaxine (Venlafaxine Hydrochloride) extende... Sep 16, 2013

Frequently Asked Questions

Stop using the medication immediately and contact your pharmacist. A mislabeling recall can range from a minor technical error (wrong font size) to a serious mix-up where one drug is inside another drug's packaging. If you received a medication that looks or acts differently than expected, or if you experienced unexpected effects, tell your doctor immediately. The pharmacist can verify whether your specific lot is affected and provide a replacement. Report any adverse effects experienced to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.